1. Home
  2. PGRE vs CRGX Comparison

PGRE vs CRGX Comparison

Compare PGRE & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGRE
  • CRGX
  • Stock Information
  • Founded
  • PGRE 1978
  • CRGX 2021
  • Country
  • PGRE United States
  • CRGX United States
  • Employees
  • PGRE N/A
  • CRGX N/A
  • Industry
  • PGRE Real Estate Investment Trusts
  • CRGX
  • Sector
  • PGRE Real Estate
  • CRGX
  • Exchange
  • PGRE Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • PGRE 1.1B
  • CRGX 964.5M
  • IPO Year
  • PGRE 2014
  • CRGX 2023
  • Fundamental
  • Price
  • PGRE $4.96
  • CRGX $21.20
  • Analyst Decision
  • PGRE Sell
  • CRGX Strong Buy
  • Analyst Count
  • PGRE 4
  • CRGX 7
  • Target Price
  • PGRE $4.38
  • CRGX $30.33
  • AVG Volume (30 Days)
  • PGRE 853.0K
  • CRGX 157.2K
  • Earning Date
  • PGRE 10-30-2024
  • CRGX 11-21-2024
  • Dividend Yield
  • PGRE 2.84%
  • CRGX N/A
  • EPS Growth
  • PGRE N/A
  • CRGX N/A
  • EPS
  • PGRE N/A
  • CRGX N/A
  • Revenue
  • PGRE $553,641,000.00
  • CRGX N/A
  • Revenue This Year
  • PGRE N/A
  • CRGX N/A
  • Revenue Next Year
  • PGRE N/A
  • CRGX N/A
  • P/E Ratio
  • PGRE N/A
  • CRGX N/A
  • Revenue Growth
  • PGRE N/A
  • CRGX N/A
  • 52 Week Low
  • PGRE $4.06
  • CRGX $13.14
  • 52 Week High
  • PGRE $5.92
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • PGRE 46.77
  • CRGX 53.07
  • Support Level
  • PGRE $4.69
  • CRGX $19.10
  • Resistance Level
  • PGRE $5.12
  • CRGX $22.56
  • Average True Range (ATR)
  • PGRE 0.18
  • CRGX 1.33
  • MACD
  • PGRE -0.04
  • CRGX -0.10
  • Stochastic Oscillator
  • PGRE 36.10
  • CRGX 50.24

About PGRE Paramount Group Inc.

Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. Paramount Group derives nearly all of its revenue in the form of rental income from leasing its offices to tenants.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: